Skip to main content
Clinical Trials/JPRN-UMIN000045917
JPRN-UMIN000045917
Completed
未知

Verification of efficacy and long-term intake safety of test food intake for liver function in healthy adults - Verification of efficacy and long-term intake safety of test food intake for liver function in healthy adults

Pharma Foods International Co., Ltd.0 sites100 target enrollmentOctober 29, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Pharma Foods International Co., Ltd.
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 29, 2021
End Date
June 24, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Subject who has been diagnosed with serious liver disease (viral hepatitis, drug\-induced liver injury, liver cirrhosis, etc.) by a doctor, or those who have a medical history or are suspected (hepatitis virus test positive, etc.) 2\.Subject who is currently undergoing medication or outpatient treatment due to some serious illness. 3\.Subject who is under exercise therapy or dietetic therapy. 4\.Subject who may develop allergies due to test foods. 5\.Subject with current or history of drug or alcohol dependence. 6\.Alcohol polydipsia. 7\.Subject who is out of the hospital due to mental disorders (depression, etc.) or sleep disorders(Insomnia, sleep apnea syndrome, etc.), or who has a history of mental illness in the past. 8\.Subject with irregular life rhythms due to night shifts or shift work. 9\.Subject who has extremely irregular lifestyle habits such as eating and sleeping. 10\.Subject who has an extremely unbalanced diet. 11\.Subject with serious current or history of brain disease, malignant tumor, immune disease, diabetes, renal disease, heart disease, thyroid disease, adrenal disease, and other metabolic diseases. 12\.Subject who uses or cannot refrain from using health foods, supplements, medicines, quasi\-drugs, Chinese medicine, etc. that contain ingredients that affect liver function (eg, ornithine, sulforaphane, turmeric, etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials